COVID-19 Vaccine Trials Hope for Breakthrough By October
A main coronavirus vaccine trial — a joint venture between an American and a German company — got underway this week in the United States. Some participants are U.S. medical students. This trial joins others around the world, as pharmaceutical companies compete to discover the breakthrough for COVID-19. VOA's Carolyn Presutti takes us through what's being done and how.
The first Canadian clinical trials for a possible COVID-19 vaccine have been approved by Health Canada. Dr. Scott Halperin, the director of the Canadian Center for Vaccinology, explains the different phases of testing that a potential vaccine would have to go through. A COVID-19 vaccine being developed in the United Kingdom may be available by September.
If successful, and with fast-tracked approval from the regulator, the first few million doses of the vaccine could be available by September.
Al Jazeera's Jonah Hull reports. American pharmaceutical giant Johnson & Johnson is fast-tracking its most promising COVID-19 vaccine and expects to have it out by January 2021 for emergency applications. But questions linger as to whether it would be made available to everyone.
CGTN's Karina Huber explains. Richard Engel reports on human trials of a COVID-19 vaccine. Aired on 04/23/2020.